Better Therapeutics, Inc. (CIK: 0001832415) EDGAR, Information, Filings... CompaniesBIO.Com

Better Therapeutics, Inc.

Mailing address
311 WEST 43RD STREET, 12TH FLOOR, NEW YORK, Delaware, 10036
Phone
646-493-6558
State location
New York
State of incorporation
Delaware
Fiscal year end
October 28
SIC
8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES
Filings
N/A

Better Therapeutics, Inc. (CIK: 0001832415) is an American company incorporated in the state of New York. Head office is located at 311 WEST 43RD STREET, 12TH FLOOR, NEW YORK, New York, 10036. Work in the industry 8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES. Better Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Mountain Crest Acquisition Corp II from 2020-18-Nov to 2021-28-Oct

Owner	Filings	Transaction Date	Type of Owner
Georgianna Maule-Ffinch 2015 Trust	0001973800	Apr-10-2023	10 percent owner
KARBE FRANK	0001276700	Jul-05-2022	director, officer: See Remarks
Granger Elder	0001625579	Nov-10-2021	director
LAVIZZO-MOUREY RISA J	0001034465	Oct-28-2021	director
PERRY DAVID P	0001105941	Oct-28-2021	director, 10 percent owner, officer: See Remarks
Carmona Richard H	0001389349	Oct-28-2021	director
Parker Geoffrey M.	0001491874	Oct-28-2021	director
Appelbaum Kevin J	0001547557	Oct-28-2021	director, 10 percent owner, officer: Chief Executive Officer
Armanino Andrew J.	0001807550	Oct-28-2021	director
Liu Suying	0001811534	Oct-28-2021	director
Heinen Mark	0001888531	Oct-28-2021	officer: See Remarks
Zamirowski Justin	0001888814	Oct-28-2021	officer: Chief Commercial Officer
Wynholds Kristin	0001889329	Oct-28-2021	officer: Chief Product Officer
Berman Mark A.	0001890348	Oct-28-2021	officer: Chief Medical Officer
David P. Perry 2015 Trust	0001890678	Oct-28-2021	10 percent owner
Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended	0001890904	Oct-28-2021	10 percent owner
Haight Nelson	0001543380	Jan-07-2021	director
Milbourn Todd T.	0001548989	Jan-07-2021	director
Liu Dong	0001813729	Jan-07-2021	director, 10 percent owner, officer: Chief Financial Officer
Mountain Crest Capital LLC	0001832411	Jan-07-2021	10 percent owner
Zhang Wenhua	0001812416	Jan-07-2020	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Better Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-24-149381 (34 Act) Size: 10 KB	May-30-2024	001-39864 241000036
EFFECT	Document	Acc-no: 9999999995-24-001656 (33 Act) Size: 1 KB	May-28-2024	333-276030 24993879
EFFECT	Document	Acc-no: 9999999995-24-001655 (33 Act) Size: 1 KB	May-28-2024	333-273861 24993877
EFFECT	Document	Acc-no: 9999999995-24-001654 (33 Act) Size: 1 KB	May-28-2024	333-271302 24993875
EFFECT	Document	Acc-no: 9999999995-24-001653 (33 Act) Size: 1 KB	May-28-2024	333-271301 24993873
EFFECT	Document	Acc-no: 9999999995-24-001652 (33 Act) Size: 1 KB	May-28-2024	333-261383 24993871
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-145859 (33 Act) Size: 18 KB	May-23-2024	333-261383 24977460
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-145858 (33 Act) Size: 18 KB	May-23-2024	333-276030 24977449
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-145856 (33 Act) Size: 20 KB	May-23-2024	333-271302 24977447
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-145855 (33 Act) Size: 20 KB	May-23-2024	333-273861 24977444
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-145853 (33 Act) Size: 20 KB	May-23-2024	333-271301 24977443
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-145852 (33 Act) Size: 19 KB	May-23-2024	333-262096 24977440
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-145850 (33 Act) Size: 19 KB	May-23-2024	333-271013 24977437
25-NSE	Document	Acc-no: 0001354457-24-000345 (34 Act) Size: 4 KB	May-16-2024	001-39864
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-24-073823 (33 Act) Size: 22 KB	Mar-21-2024	333-276030 24771251
8-K	Document	Current report filing Acc-no: 0001193125-24-073819 (34 Act) Size: 143 KB	Mar-21-2024	001-39864 24771213
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-24-068674 (33 Act) Size: 26 KB	Mar-15-2024	333-276030 24752799
8-K	Document	Current report filing Acc-no: 0001193125-24-068672 (34 Act) Size: 148 KB	Mar-15-2024	001-39864 24752785
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-24-067486 (33 Act) Size: 28 KB	Mar-14-2024	333-276030 24748161
8-K	Document	Current report filing Acc-no: 0001193125-24-067483 (34 Act) Size: 152 KB	Mar-14-2024	001-39864 24748155

Recent 20 filings. View all Better Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Better Therapeutics, Inc. overview
Better Therapeutics, Inc. job
Better Therapeutics, Inc. stock
Better Therapeutics, Inc. ownership
Better Therapeutics, Inc. CEO
Better Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.